Arthritis und Rheuma 2018; 38(05): 363-366
DOI: 10.1055/s-0038-1675730
Kinderrheumatologie
Georg Thieme Verlag KG Stuttgart · New York

Takayasu-Arteriitis des Kindesalters nach allogener Stammzelltransplantation bei Hyper-IgE-Syndrom mit Nachweis einer NOD2-Mutation

C. Reiser
1   Landeskrankenhaus Bregenz, Abteilung für Kinder- und Jugendheilkunde, Bregenz, Österreich
,
A. Kurringer
1   Landeskrankenhaus Bregenz, Abteilung für Kinder- und Jugendheilkunde, Bregenz, Österreich
,
A. Lawitschka
2   St. Anna Kinderspital, Medizinische Universität Wien, Wien, Österreich
,
A. Schuster
3   Landeskrankenhaus Bregenz, Abteilung für Radiologie, Bregenz, Österreich
,
J. B. Kuemmerle-Deschner
4   Division of Rheumatology, Department of Pediatrics, University hospital Tuebingen und autoinflammation reference center Tuebingen, Tuebingen, Deutschland
,
C. Huemer
1   Landeskrankenhaus Bregenz, Abteilung für Kinder- und Jugendheilkunde, Bregenz, Österreich
› Author Affiliations
Further Information

Korrespondenzadresse

Dr. Christiane Reiser
LKH Bregenz, Kinderabteilung
Carl-Pedenz-Straße 2, A-6900 Bregenz Österreich

Publication History

Publication Date:
30 October 2018 (online)

 

 


#

Interessenkonflikt

Die korrespondieren Autorin gibt an, dass kein Interessenkonflikt besteht.

  • Literatur

  • 1 Dolezalova et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activitiy Score (PVAS). Ann Rheum Dis 2013; 72 (10) 1795-1801.
  • 2 Mathew A, Goel R, Kumar S, Danda D. Childhoodonset Takayasu arteritis: an update. Int J Rheum Dis 2016; 19 (02) 116-126.
  • 3 Dagna L, Salvo F, Tiraboschi M. et al. Pentraxin-3 as a marker for disease activity in Takayasu arteritis. Ann Intern Med 2011; 155: 425-433.
  • 4 Sun Y, Ma L, Yan F. et al. MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu’s arteritis. Int J Cardiol 2012; 156: 236-238.
  • 5 Papa M, De Cobelli F, Baldissera E. et al. Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol 2012; 198: W279-284.
  • 6 Hoffmann M, Corr P, Robbs J. Cerebrovascular findings in Takayasu disease. J Neuroimaging 2000; 10: 84-90.
  • 7 Aeschlimann F. et al. Childhood Takayasu arteritis: disease course and response to therapy. Arthritis Research & Therapy 2017; 19: 255.
  • 8 Ozen S, Duzova A, Bakkaloglu A. et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr 2007; 150: 72-76.
  • 9 Snowden JA, Saccardi R, Allez M. et al. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2012; 47 (06) 770-790.
  • 10 Daikeler T. et al. Haematopoietic stem cell transplantation for vasculitis including Behçet’s disease and polychondritis: a retrospective analysis of patients recor. Annals of the Rheumatic Diseases 2007; 66 (02) 202-207.
  • 11 Hyvärinen K, Ritari J, Koskela S. et al. Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host disease. Scientific Reports 2017; 07: 15666.
  • 12 Khubchandani R, Hasija R, Touitou I. et al. Blau Arteritis Resembling Takayasu Disease with a Novel NOD2 Mutation. The Journal of Rheumatology 2012; 39 (09) 1888-1892.

Korrespondenzadresse

Dr. Christiane Reiser
LKH Bregenz, Kinderabteilung
Carl-Pedenz-Straße 2, A-6900 Bregenz Österreich

  • Literatur

  • 1 Dolezalova et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activitiy Score (PVAS). Ann Rheum Dis 2013; 72 (10) 1795-1801.
  • 2 Mathew A, Goel R, Kumar S, Danda D. Childhoodonset Takayasu arteritis: an update. Int J Rheum Dis 2016; 19 (02) 116-126.
  • 3 Dagna L, Salvo F, Tiraboschi M. et al. Pentraxin-3 as a marker for disease activity in Takayasu arteritis. Ann Intern Med 2011; 155: 425-433.
  • 4 Sun Y, Ma L, Yan F. et al. MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu’s arteritis. Int J Cardiol 2012; 156: 236-238.
  • 5 Papa M, De Cobelli F, Baldissera E. et al. Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol 2012; 198: W279-284.
  • 6 Hoffmann M, Corr P, Robbs J. Cerebrovascular findings in Takayasu disease. J Neuroimaging 2000; 10: 84-90.
  • 7 Aeschlimann F. et al. Childhood Takayasu arteritis: disease course and response to therapy. Arthritis Research & Therapy 2017; 19: 255.
  • 8 Ozen S, Duzova A, Bakkaloglu A. et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr 2007; 150: 72-76.
  • 9 Snowden JA, Saccardi R, Allez M. et al. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2012; 47 (06) 770-790.
  • 10 Daikeler T. et al. Haematopoietic stem cell transplantation for vasculitis including Behçet’s disease and polychondritis: a retrospective analysis of patients recor. Annals of the Rheumatic Diseases 2007; 66 (02) 202-207.
  • 11 Hyvärinen K, Ritari J, Koskela S. et al. Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host disease. Scientific Reports 2017; 07: 15666.
  • 12 Khubchandani R, Hasija R, Touitou I. et al. Blau Arteritis Resembling Takayasu Disease with a Novel NOD2 Mutation. The Journal of Rheumatology 2012; 39 (09) 1888-1892.